Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Non Operating Income (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Non Operating Income for 7 consecutive years, with $181000.0 as the latest value for Q4 2024.

  • Quarterly Non Operating Income rose 341.46% to $181000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $632000.0 through Dec 2024, up 19.47% year-over-year, with the annual reading at $1.4 million for FY2025, 123.26% up from the prior year.
  • Non Operating Income for Q4 2024 was $181000.0 at SELLAS Life Sciences, down from $221000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $325000.0 in Q4 2022, with the low at $41000.0 in Q4 2023.
  • Average Non Operating Income over 3 years is $165363.6, with a median of $181000.0 recorded in 2024.
  • The sharpest move saw Non Operating Income tumbled 87.38% in 2023, then skyrocketed 341.46% in 2024.
  • Over 3 years, Non Operating Income stood at $325000.0 in 2022, then crashed by 87.38% to $41000.0 in 2023, then surged by 341.46% to $181000.0 in 2024.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $181000.0, $221000.0, and $151000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.